Florin Timothy H J, Paterson Ewan W J, Fowler Elizabeth V, Radford-Smith Graham L
Brisbane IBD Research Group, Department of Medicine and ECMB Laboratory, University of Queensland, Mater Medical Research Institute, South Brisbane, Australia.
Scand J Gastroenterol. 2006 Mar;41(3):306-11. doi: 10.1080/00365520500217118.
Clinical interest in C-reactive protein (CRP) -- a component of the innate immune system -- has focused mainly on its worth as an indicator of disease activity. There has been a resurgence of interest in CRP in the Crohn's disease (CD) literature because several trials of new treatments for active CD have been characterized by both a large proportion of patients with low CRP (<10 mg/l) at entry to the trials and by a negative therapeutic outcome. It is therefore of interest to study the clinical characteristics of patients who are thought to have at the same time both active CD and a low CRP.
Patients were prospectively recruited as part of the Brisbane IBD clinical and research programme. Subjects were included in the low CRP group only if there were complete datasets for CRP on all occasions of active CD, and CRP was < 10 mg/l. Active disease was defined as CD activity index (CDAI)>200. The low CRP group was compared with patients in the raised CRP group for a range of clinical variables as well as the major NOD2 variants.
There were data sets for 223 CD patients, with a mean disease duration of 12 years. Of these, 22 patients fulfilled the criteria for low CRP. The low CRP group (group 1) showed significant differences for disease site (p<0.01) and for BMI (p=0.006) compared to the raised CRP group (group 2). Specifically, group 1 had a predominance of pure ileal disease (95% versus 53%) and lack of pure colonic disease (0% versus 24%) compared to group 2, and their BMI was significantly lower (20.3 kg/m(2) versus 25.0 kg/m(2)). Groups 1 and 2 did not differ with respect to Vienna behaviour at diagnosis, smoking, appendicectomy, extra-intestinal manifestations of CD, or NOD2 SNP variants. There was a trend for low CRP patients with previous ileal resection to evolve to a stricturing phenotype. Fat wrapping was noted in 11/13 (85%) of low CRP patients undergoing ileal resections.
Patients with CD and a persistently low CRP in the face of active disease were characterized by an almost exclusive ileal disease distribution and a low BMI, compared to those with a raised CRP. These patients had a similar frequency and distribution of NOD2/CARD15 variants. Stricturing (v inflammatory or penetrating) behaviour may explain some low CRP. Despite the abnormally low BMI, fat wrapping was noted in the majority of low CRP patients undergoing ileal resection.
C反应蛋白(CRP)作为先天性免疫系统的一个组成部分,临床上对其关注主要集中在它作为疾病活动指标的价值上。在克罗恩病(CD)文献中,对CRP的兴趣再度兴起,因为几项针对活动性CD的新治疗方法的试验有两个特点,一是入组试验的患者中有很大比例CRP水平较低(<10mg/L),二是治疗结果为阴性。因此,研究那些被认为同时患有活动性CD且CRP水平较低的患者的临床特征很有意义。
作为布里斯班炎症性肠病临床与研究项目的一部分,前瞻性招募患者。仅当在所有活动性CD发作时都有完整的CRP数据集且CRP<10mg/L时,受试者才被纳入低CRP组。活动性疾病定义为CD活动指数(CDAI)>200。将低CRP组与CRP升高组的患者在一系列临床变量以及主要NOD2变异方面进行比较。
有223例CD患者的数据集,平均病程为12年。其中,22例符合低CRP标准。与CRP升高组(第2组)相比,低CRP组(第1组)在疾病部位(p<0.01)和体重指数(BMI)(p=0.006)方面存在显著差异。具体而言,与第2组相比,第1组以单纯回肠疾病为主(95%对53%)且无单纯结肠疾病(0%对24%),其BMI显著更低(20.3kg/m²对25.0kg/m²)。第1组和第2组在诊断时的维也纳行为、吸烟、阑尾切除术、CD的肠外表现或NOD2单核苷酸多态性变异方面无差异。既往有回肠切除术的低CRP患者有发展为狭窄型表型的趋势。在接受回肠切除术的低CRP患者中,11/13(85%)发现有脂肪包裹。
与CRP升高的患者相比,患有CD且在活动性疾病情况下CRP持续较低的患者,其疾病几乎完全局限于回肠且BMI较低。这些患者NOD2/CARD15变异的频率和分布相似。狭窄(与炎症或穿透性相对)行为可能解释了一些低CRP情况。尽管BMI异常低,但在大多数接受回肠切除术的低CRP患者中发现有脂肪包裹。